Xiang Ren

机构：University of Southern California, Sichuan University, WuXi AppTec (China), California Southern University, West China Hospital of Sichuan University, Wuhou District People's Hospital, Chengdu, State Key Laboratory of Biotherapy · ORCID：0000-0002-9923-6077

发表论文 81 篇 · 总被引 1591 次 · h-index 21

代表论文

• A Mettl16/m6A/mybl2b/Igf2bp1 axis ensures cell cycle progression of embryonic hematopoietic stem and progenitor cells (2024 · The EMBO Journal · 被引 21)
• Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases (2023 · Frontiers in Immunology · 被引 21)
• EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma (2022 · Frontiers in Genetics · 被引 12)
• REL-A.I.: An Interaction-Centered Approach To Measuring Human-LM Reliance (2025 · 被引 10)
• Exploring the influence of nasal vestibule structure on nasal obstruction using CFD and Machine Learning method (2023 · Medical Engineering & Physics · 被引 10)
• The splicing factor DHX38 enables retinal development through safeguarding genome integrity (2023 · iScience · 被引 6)